For many companies considering a U.S. listing, a common and crucial question often arises:
Should we choose NASDAQ, or start with the OTC markets?
At the core of this decision lies an understanding of how the market maker system operates differently in these two markets. While both NASDAQ and OTC markets adopt a market maker mechanism, they diverge significantly in terms of system design, execution processes, and regulatory requirements.
Below, we break down the five key differences between the NASDAQ and OTC markets in terms of their market maker mechanisms—helping you craft a clearer capital strategy for your company.
1. Number of Market Makers Required: Entry Barriers Differ
To initiate a listing on NASDAQ, a company must have at least two FINRA-approved market makers quoting its shares. This reflects higher requirements for market liquidity and depth.
In contrast, the OTC markets has a much lower entry threshold—only one market maker is needed to initiate quoting and start the application process. This setup provides a more accessible pathway for SMEs and startups, often serving as the first step in a “stealth” U.S. listing strategy.
2. Listing Process: IPO and SEC Registration Requirements
NASDAQ follows a more rigorous process. Market makers must file Form 211 and obtain FINRA approval. Companies are also typically required to conduct an IPO or file for SEC registration, adhering to a fully compliant listing path.
On the other hand, the OTC markets allows listings without an IPO. A market maker can initiate the process by submitting a quote directly. This is especially true for OTCQB and OTC Pink, which offer more flexibility and are suitable for companies seeking overseas exposure with limited resources.
3. Trade Matching & Market Transparency
NASDAQ uses an automated matching system where all quotes and trade prices are public and updated in real-time. This high level of transparency helps form a more efficient and fair market price.
In contrast, the OTC markets relies more on manual quoting by market makers. The information disclosure is slower, and quotes are not always updated instantly—leading to occasional inefficiencies in price reflection.
4. Regulatory Oversight: Main Board vs. Off-Exchange
NASDAQ is a national securities exchange regulated by the SEC, with strict requirements for corporate governance, audited financials, and periodic disclosures. It’s suitable for companies ready to meet main board-level compliance challenges.
The OTC markets, especially OTC Pink, is more lenient—there’s no mandatory annual audit or strict governance standards. This makes it more accommodating for early-stage companies, though it may also result in lower investor confidence and more conservative valuations.
5. Suitable Company Profiles: Strategic Goals & Stage Matter
NASDAQ is ideal for: Mature or mid-to-large companies with stable revenue, strong audit records, and robust governance—those looking to maximize valuation and brand presence on the international stage.
OTC markets is ideal for: Startups or fast-growing small companies that haven’t yet met main board thresholds. It’s best for those looking to control costs, minimize equity dilution, and gradually build capital market visibility.
Listing in the U.S. is not a one-shot gamble, but a strategic, phased journey. If your current revenue and resources don’t meet main board standards, the OTC markets offers a practical and often underrated starting point. Once you’re ready, NASDAQ becomes the clear path to drive up valuation and attract institutional capital
